Literature DB >> 28503562

The natural history of nonalcoholic fatty liver disease: mortality rates and liver enzymes.

Carlos J Pirola1,2, Silvia Sookoian1,3.   

Abstract

Entities:  

Year:  2017        PMID： 28503562      PMCID： PMC5411275          DOI： 10.21037/hbsn.2017.03.02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

Review 1.  Gamma-glutamyltransferase predicts increased risk of mortality: a systematic review and meta-analysis of prospective observational studies.

Authors:  Y Long; F Zeng; J Shi; H Tian; T Chen
Journal:  Free Radic Res       Date:  2014-04-01

Review 2.  Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis.

Authors:  Abigail Fraser; Ross Harris; Naveed Sattar; Shah Ebrahim; George Davey Smith; D A Lawlor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-11       Impact factor: 8.311

Review 3.  Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 4.  Gamma glutamyl transferase.

Authors:  J B Whitfield
Journal:  Crit Rev Clin Lab Sci       Date:  2001-08       Impact factor: 6.250

Review 5.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

6.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

Review 7.  Nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Vincent W-S Wong; Valerio Nobili; Christopher P Day; Silvia Sookoian; Jacquelyn J Maher; Elisabetta Bugianesi; Claude B Sirlin; Brent A Neuschwander-Tetri; Mary E Rinella
Journal:  Nat Rev Dis Primers       Date:  2015-12-17       Impact factor: 52.329

8.  The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis.

Authors:  Carlos J Pirola; Silvia Sookoian
Journal:  Hepatology       Date:  2015-10-29       Impact factor: 17.425

9.  A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

Authors:  Silvia Sookoian; Gustavo O Castaño; Adriana L Burgueño; Tomas Fernández Gianotti; María Soledad Rosselli; Carlos Jose Pirola
Journal:  J Lipid Res       Date:  2009-10       Impact factor: 5.922

10.  Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2016-01-22       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.